Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

PAYX Stock Plummets – Uncovering the Reasons

This afternoon we watched Paychex drop -2.2% to a price of $114.5 per share. The Large-Cap Commercial Services company is now trading -15.01% below its average target price of $134.71. Analysts have set target prices ranging from $122.0 to $150.0 per share for Paychex, and have given the stock an average rating of hold.

The stock has an average amount of shares sold short at 4.0%, and a short ratio of 3.66. The company's insiders own 10.53% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 83.2% of Paychex's shares being owned by this investor type.

Institutions Invested in Paychex

Date Reported Holder Percentage Shares Value
2025-06-30 Vanguard Group Inc 9% 32,215,957 $3,688,727,076
2025-06-30 Blackrock Inc. 8% 27,369,482 $3,133,805,689
2025-06-30 Capital International Investors 6% 22,514,178 $2,577,873,381
2025-06-30 State Street Corporation 4% 14,066,067 $1,610,564,671
2025-06-30 Charles Schwab Investment Management, Inc. 3% 11,033,312 $1,263,314,224
2025-06-30 Geode Capital Management, LLC 3% 10,183,871 $1,166,053,229
2025-06-30 Wells Fargo & Company 2% 8,972,130 $1,027,308,885
2025-06-30 Bank Of New York Mellon Corporation 2% 8,692,386 $995,278,197
2025-06-30 Bank of America Corporation 2% 5,804,606 $664,627,387
2025-06-30 Northern Trust Corporation 1% 4,932,209 $564,737,930

Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on Paychex.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS